I respect your endorsement here. I have a fly on the wall perspective and have followed a few small biotecks and have personally known all the characters. The wisdom I learned after appearing in bankrupcy court in Oakland is that businessmen can overwhelm even the most honest and well based scientific start-ups.
Does anyone remember BIORESPONSE? Now a division of BAXTER INTL.
Same company, same staff (originally) all shareholders dumped when BAXTER bought the company for firesale prices even though it had to keep Factor 8 running or lose lose lose.
Beware of all small poorly funded start-ups. They are subject to businessmen's manipulation.
ATHX has enough funds to keep running its many interesting and beneficial FDA testing of conditions that help termanily ill persons like those with colitus. And probably similiar conditions like ulcers I am guessing.
Someone said that Pfizer might give 250 to 350 Mil to buy out ATHX. That seems strange. If Pfizer already have put up 111Mil against FDA tests, would you add that 111MIL to the buy out sum.
My opinion, ATHX share price will rachet up most everyday. It seems to me that the word is out that this is a hot stock in a hot BIOTECk market in a huge bubble stock market.